tiprankstipranks
NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
PremiumThe FlyNeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
10d ago
NeuroPace price target raised to $14 from $9 at JPMorgan
Premium
The Fly
NeuroPace price target raised to $14 from $9 at JPMorgan
1M ago
NeuroPace completes enrollment in RNS System IDE study
Premium
The Fly
NeuroPace completes enrollment in RNS System IDE study
2M ago
NPCE Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsNPCE Upcoming Earnings Report: What to Expect?
2M ago
NeuroPace submits safety, effectiveness data from RNS System study to FDA
Premium
The Fly
NeuroPace submits safety, effectiveness data from RNS System study to FDA
2M ago
NeuroPace price target lowered to $15 from $20 at Wells Fargo
Premium
The Fly
NeuroPace price target lowered to $15 from $20 at Wells Fargo
5M ago
Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
PremiumThe FlyLake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
6M ago
NeuroPace post Q1 move ‘overdone,’ says Lake Street
Premium
The Fly
NeuroPace post Q1 move ‘overdone,’ says Lake Street
8M ago
Neuropace’s Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies
Premium
Company Announcements
Neuropace’s Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100